![](/img/cover-not-exists.png)
Durable complete response after afatinib and crizotinib in an advanced non-small cell lung cancer patient with EGFR L861Q mutation and acquired MET amplification: a case report
Long, Yaling, Zhang, Kai, Li, Yanying, Yu, Min, Zhu, Jiao, Huang, MeijuanVolume:
9
Journal:
Annals of Palliative Medicine
DOI:
10.21037/apm-19-482
Date:
July, 2020
File:
PDF, 694 KB
2020